Retroviral vectors for persistent expression in vivo
- 31 October 1992
- journal article
- review article
- Published by Elsevier in Current Opinion in Biotechnology
- Vol. 3 (5) , 540-547
- https://doi.org/10.1016/0958-1669(92)90083-u
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Gene therapy via primary myoblasts: long-term expression of factor IX protein following transplantation in vivo.Proceedings of the National Academy of Sciences, 1992
- Human gene therapy comes of ageNature, 1992
- Human gene therapyScience, 1992
- An in Vivo Model of Somatic Cell Gene Therapy for Human Severe Combined ImmunodeficiencyScience, 1991
- Gene TherapyScientific American, 1990
- Gene Transfer into Humans — Immunotherapy of Patients with Advanced Melanoma, Using Tumor-Infiltrating Lymphocytes Modified by Retroviral Gene TransductionNew England Journal of Medicine, 1990
- Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection.Molecular and Cellular Biology, 1990
- Highly preferred targets for retrovirus integrationCell, 1988
- Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirusCell, 1983
- Mechanism of antibody-independent activation of the first component of complement (C1) on retrovirus membranesBiochemistry, 1980